After being sworn in as the director of the U.S. Army Edgewood Chemical Biological Center (ECBC) on Thursday, Dr. Eric Moore called for effective partnerships with chemical and biological defense stakeholders, academia and industry to develop technologies of the future for warfighters.
Moore, who joined ECBC in 2016 as director of the Research and Technology Directorate, was appointed to serve as the permanent ECBC director in October. He has been serving as acting director since May.
“We only select the finest for leadership positions here, and Dr. Eric Moore certainly meets all those criteria,” Maj. Gen. Cedric Wins, the commanding general of the Army Research, Development and Engineering Command, said. “He’s considered by his peers and superiors to be a subject matter expert in these fields. He has a sense of duty and passion for science.”
Moore, who earned a doctorate in neurophysiology from Meharry Medical College in Nashville, has served with the Army Medical Service Corps, the Army Medical Research Institute of Chemical Defense and the Armed Forces Medical Intelligence Center, where he was senior scientific and technical intelligence officer for worldwide chemical, biological, radiological and nuclear (CBRN) defense.
During his swearing-in ceremony, Moore highlighted the importance of ECBC aligning its mission with the Army’s top priorities: readiness, modernization, and reform.
“We have to ensure that we’re growing the talent and infrastructure to support tomorrow’s fight,” he said. “We have to make sure that we’re putting the right business processes in place to deliver quality products and services to tomorrow’s warfighter. And we have to collaborate with one another to deliver tomorrow’s technology using common platforms.”